Tag: obesity

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Novo Nordisk is launching Wegovy® pill in the UAE, the first country outside the US, to make the Wegovy® pill available to people living with obesity

Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update

Revenue Increased to $24.9 Million, Net Income Totaled $3.9 Million, and Cash & Marketable Securities Increased to Approximately $31 Million VANCOUVER, BC, June 1, 2026...

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy^® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile

Functional Foods Market Surges to USD 654.45 Billion by 2033, Propelled by 10.4% CAGR – Verified Market Reports®

The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...

Functional Foods Market Surges to USD 654.45 Billion by 2033, Propelled by 10.4% CAGR – Verified Market Reports®

The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...

Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries

OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national...

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

OIKOS® Launches First-of-Its-Kind Cultured Dairy Drink Featuring A Patented Blend of Nutrients Designed to Help Build & Retain Muscle Mass During Weight Loss

New OIKOS FUSION™ is the first product in the yogurt category with a proprietary combination of whey, leucine and vitamin D designed to support...

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

- The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsObesity

Director/PDMR Shareholding

Aptean Appoints Yama Habibzai as Chief Marketing Officer

Taboola Announces Inclusion in Russell 3000® and 2000® Index

Tag: obesity

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

Functional Foods Market Surges to USD 654.45 Billion by 2033, Propelled by 10.4% CAGR – Verified Market Reports®

Functional Foods Market Surges to USD 654.45 Billion by 2033, Propelled by 10.4% CAGR – Verified Market Reports®

Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

OIKOS® Launches First-of-Its-Kind Cultured Dairy Drink Featuring A Patented Blend of Nutrients Designed to Help Build & Retain Muscle Mass During Weight Loss

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

Study Reveals How Small Changes in Walking Technique May Help Treat Knee Osteoarthritis

Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering

Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates

Lilly reports second-quarter 2025 financial results and raises guidance

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us